SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-006338
Filing Date
2024-02-14
Accepted
2024-02-14 08:34:40
Documents
16
Period of Report
2024-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 59974
2 ex99-1.htm EX-99.1 18109
3 ex99-1_001.jpg GRAPHIC 4714
  Complete submission text file 0001493152-24-006338.txt   265764

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE vbiv-20240214.xsd EX-101.SCH 3024
5 XBRL LABEL FILE vbiv-20240214_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE vbiv-20240214_pre.xml EX-101.PRE 22365
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3528
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 24632601
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)